Sign in

CIK 0000894158

  • Non-accelerated filer
  • Smaller reporting company

Theriva Biologics, Inc.

Sign in to watch
Ticker
TOVX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
133808303
Phone
+1 734-332-7800
Business address
9605 MEDICAL CENTER DRIVE, SUITE 270, ROCKVILLE, MD, 20850
Former names
Synthetic Biologics, Inc., ADEONA PHARMACEUTICALS, INC., PIPEX PHARMACEUTICALS, INC., SHEFFIELD PHARMACEUTICALS INC, SHEFFIELD MEDICAL TECHNOLOGIES INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy CEO and President bought 2,900 shares at an average $0.17 ($506)
  7. 4 Open-market buy CEO and President bought 2,000 shares at $1.71 ($3,420)
  8. 4 Open-market buy CEO and President bought 5,500 shares at an average $1.76 ($9,705)
  9. 4 Open-market buy 10% owner bought 3,125,000 shares at $1.60 ($5,000,000)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market buy Chairman, CEO & President bought 4,500 shares at $0.69 ($3,103)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 8 · 156 filings